PubMed · 1992 · 78 citations · 23 references
Life SciencesImmunologyInfectious DiseasesInnate ImmunityNeuroimmunologyNeuroinfectious DiseasesBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionCentral Nervous System InfectionsEncephalitisNeuroinflammationNeuroprotectionBarrier LeakageBlood-brain Barrier PermeabilityBlood-brain Barrier ProtectionCytokine-mediated Barrier DisruptionCytokine-mediated Barrier InjuryCytokine-mediated Barrier ModulationLeakage
In this study we have shown, for the first time, that Japanese encephalitis virus (JEV) and a low molecular weight (10 kDa) macrophage-derived neutrophil chemotactic factor (MDF) produced following JEV infection in mice could cause an alteration in the permeability of the blood-brain barrier resulting in leakage of plasma protein bound Evans blue dye and radiolabelled erythrocytes in brain. The maximum leakage occurred at day 6 after intracerebral (i.c.) JEV infection and was sensitive to anti-JEV antisera. Further, MDF caused peak leakage of dye and radiolabelled erythrocytes at 1 h post inoculation with a decline thereafter. Complete restoration of the integrity of the blood-brain barrier occurred by the 4th hour. The extent of leakage was dose dependent and showed a direct correlation between the level of MDF, clinical sickness and virus titre in brain. Anti-MDF antisera protected the mice against the effects of MDF. These findings show that JEV-induced cytokine, MDF, alters the integrity of the blood-brain barrier and thus controls the cellular and plasma leakage into the CNS.
23
Teizo Yoshimura, Kisa Matsushima, Joost J. Oppenheim et al. · The Journal of Immunology · 1987 · 611 citations · Full text
Japanese encephalitis: current worldwide status.
Takusei Umenai, R. Krzysko, T. A. Bektimirov et al. · PubMed · 1985 · 238 citations